Atlas Trials

The Role of Hepcidin as a Biomarker to Predict Successful Renal Transplantation

Clinical trial NCT04575077 · UNKNOWN

Trial details

NCT number
NCT04575077
Sponsor
Yonsei University
Status
UNKNOWN
Study type
OBSERVATIONAL
End-stage Renal Disease
Start date
2020-09-16
Primary completion
2022-02-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.